Form 4: LifeCore Biomedical CFO Ryan Lake Reports Stock Transactions

LifeCore Biomedical's Chief Financial Officer, Ryan Lake, reported the acquisition and disposal of company stock on December 6, 2024, including shares withheld for tax obligations.

Summary

• Ryan Lake, the Chief Financial Officer of LifeCore Biomedical, reported a transaction involving the company's common stock on December 6, 2024.
• Mr. Lake acquired 19,720 shares of common stock at a price of $0.
• He also disposed of 5,653 shares at a price of $7.15 per share to cover tax obligations related to the stock grant.
• Following these transactions, Mr. Lake beneficially owns 317,429 shares of LifeCore Biomedical common stock.

Sentiment

Score: 6

Explanation: The document reflects routine insider transactions. While the acquisition is positive, the disposal for tax purposes is neutral. Overall, the sentiment is slightly positive.

Positives

• The acquisition of 19,720 shares by the CFO indicates confidence in the company's future.

Negatives

• The disposal of 5,653 shares, while for tax purposes, could be perceived negatively by some investors.

Risks

• The sale of shares by an executive, even for tax purposes, can sometimes be interpreted as a lack of confidence in the company's future performance.

Industry Context

This is a routine filing related to insider trading and is common for publicly traded companies. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The transactions reported are typical for executives receiving stock-based compensation and covering tax obligations.

Stakeholder Impact

• The transactions have a minor impact on shareholders, providing transparency into executive stock ownership.
• The disposal of shares for tax obligations is a standard practice and should not significantly impact stakeholders.

Key Dates

Keywords

LifeCore Biomedical, LFCR, Ryan Lake, CFO, stock transaction, Form 4, insider trading, beneficial ownership